Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability

A Model for Foam Cell Death

From the Department of Biochemistry, Allegheny University of the Health Sciences, Philadelphia, Pa (G.K.-W., G.J.W., M.C.P., G.H.R.); the Department of Pathology, Bowman Gray School of Medicine, Winston-Salem, NC (W.G.J.); the Department of Biophysics, Boston University School of Medicine, Boston, Mass (D.M.S.); and the Dupont Merck Research Laboratories, Wilmington, Del (J.K.S., M.A.K., M.H.C.).

Correspondence to Dr George H. Rothblat, Department of Biochemistry, Allegheny University of the Health Sciences, 2900 Queen Lane, Philadelphia, PA 19129.

Abstract—This study was designed to identify cellular responses associated with free cholesterol (FC) accumulation in model macrophage foam cells. Mouse peritoneal macrophages (MPMs) or J774 macrophages were loaded with cholesteryl esters using acetylated LDL and FC/phospholipid dispersions and were subsequently exposed to an acyl coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. This treatment produced a rapid accumulation of cellular FC. The FC that accumulated due to ACAT inhibition was more readily available for efflux to 2-hydroxypropyl-ß-cyclodextrin (which removes cholesterol from the plasma membrane) than FC in untreated control cells. After a 3-hour exposure to an ACAT inhibitor, a significant increase in phospholipid synthesis was seen, followed by the leakage of LDH after 12 hours of treatment. We also observed, by electron and fluorescence microscopy, morphological indications of both apoptosis and necrosis in cells treated with an ACAT inhibitor. In addition, inhibition of ACAT for 48 hours resulted in the formation of FC crystals in MPMs but not in J774 cells. If compound 3ß-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A), which modulates intracellular trafficking of cholesterol, was added together with the ACAT inhibitor, each of the metabolic changes elicited by the accumulation of excess FC was either diminished or eliminated. The protective affect of U18666A was not due to a decrease in cellular FC concentrations, because cells treated with an ACAT inhibitor accumulated similar amounts of FC in the presence or absence of U18666A. Thus, treatment with U18666A results in the sequestering of FC in a pool that prevents it from causing various responses to FC deposition in macrophages. The metabolic changes that were produced when these model foam cells were treated with the ACAT inhibitor parallel the pathological events that have been shown to occur in the developing atherosclerotic plaque.

Key Words: cholesterol • macrophage • foam cell

This article has been cited by other articles:

				D. Cui, E. Thorp, Y. Li, N. Wang, L. Yvan-Charvet, A. R. Tall, and I. Tabas Pivotal Advance: Macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells J. Leukoc. Biol., November 1, 2007; 82(5): 1040 - 1050. [Abstract] [Full Text] [PDF]

				G. L. Weibel, E. T. Alexander, M. R. Joshi, D. J. Rader, S. Lund-Katz, M. C. Phillips, and G. H. Rothblat Wild-Type ApoA-I and the Milano Variant Have Similar Abilities to Stimulate Cellular Lipid Mobilization and Efflux Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2022 - 2029. [Abstract] [Full Text] [PDF]

				Y. Li and I. Tabas The inflammatory cytokine response of cholesterol-enriched macrophages is dampened by stimulated pinocytosis J. Leukoc. Biol., February 1, 2007; 81(2): 483 - 491. [Abstract] [Full Text] [PDF]

				L. Bao, Y. Li, S.-X. Deng, D. Landry, and I. Tabas Sitosterol-containing Lipoproteins Trigger Free Sterol-induced Caspase-independent Death in ACAT-competent Macrophages J. Biol. Chem., November 3, 2006; 281(44): 33635 - 33649. [Abstract] [Full Text] [PDF]

				B. Zhao, Y. Li, C. Buono, S. W. Waldo, N. L. Jones, M. Mori, and H. S. Kruth Constitutive Receptor-independent Low Density Lipoprotein Uptake and Cholesterol Accumulation by Macrophages Differentiated from Human Monocytes with Macrophage-Colony-stimulating Factor (M-CSF) J. Biol. Chem., June 9, 2006; 281(23): 15757 - 15762. [Abstract] [Full Text] [PDF]

				R. P. Mason, M. F. Walter, C. A. Day, and R. F. Jacob Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism J. Biol. Chem., April 7, 2006; 281(14): 9337 - 9345. [Abstract] [Full Text] [PDF]

				A. Yesilaltay, M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger Effects of Hepatic Expression of the High-Density Lipoprotein Receptor SR-BI on Lipoprotein Metabolism and Female Fertility Endocrinology, April 1, 2006; 147(4): 1577 - 1588. [Abstract] [Full Text] [PDF]

				S. E. Nissen, E. M. Tuzcu, H. B. Brewer, I. Sipahi, S. J. Nicholls, P. Ganz, P. Schoenhagen, D. D. Waters, C. J. Pepine, T. D. Crowe, et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med., March 23, 2006; 354(12): 1253 - 1263. [Abstract] [Full Text] [PDF]

				T. DeVries-Seimon, Y. Li, P. M. Yao, E. Stone, Y. Wang, R. J. Davis, R. Flavell, and I. Tabas Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor J. Cell Biol., October 10, 2005; 171(1): 61 - 73. [Abstract] [Full Text] [PDF]

				A. Sakurai, S.-y. Morita, K. Wakita, Y. Deharu, M. Nakano, and T. Handa Effects of cholesterol in chylomicron remnant models of lipid emulsions on apoE-mediated uptake and cytotoxicity of macrophages J. Lipid Res., October 1, 2005; 46(10): 2214 - 2220. [Abstract] [Full Text] [PDF]

				L. L. Rudel, R. G. Lee, and P. Parini ACAT2 Is a Target for Treatment of Coronary Heart Disease Associated With Hypercholesterolemia Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1112 - 1118. [Abstract] [Full Text] [PDF]

				T. Q. Nhan, W. C. Liles, and S. M. Schwartz Role of Caspases in Death and Survival of the Plaque Macrophage Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 895 - 903. [Abstract] [Full Text] [PDF]

				M. S. Spagnuolo, L. Cigliano, L. D. D'Andrea, C. Pedone, and P. Abrescia Assignment of the Binding Site for Haptoglobin on Apolipoprotein A-I J. Biol. Chem., January 14, 2005; 280(2): 1193 - 1198. [Abstract] [Full Text] [PDF]

				S. Fazio, D. E. Dove, and M. F. Linton ACAT Inhibition: Bad for Macrophages, Good for Smooth Muscle Cells? Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 7 - 9. [Full Text] [PDF]

				D. E. Dove, Y. R. Su, W. Zhang, W. G. Jerome, L. L. Swift, M. F. Linton, and S. Fazio ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 128 - 134. [Abstract] [Full Text] [PDF]

				J. X. Rong, J. Kusunoki, P. Oelkers, S. L. Sturley, and E. A. Fisher Acyl-CoenzymeA (CoA):Cholesterol Acyltransferase Inhibition in Rat and Human Aortic Smooth Muscle Cells Is Nontoxic and Retards Foam Cell Formation Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 122 - 127. [Abstract] [Full Text] [PDF]

				R. P. Mason, M. F. Walter, and R. F. Jacob Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress Circulation, June 1, 2004; 109(21_suppl_1): II-34 - II-41. [Abstract] [Full Text] [PDF]

				A. R. Leventhal, C. C. Leslie, and I. Tabas Suppression of Macrophage Eicosanoid Synthesis by Atherogenic Lipoproteins Is Profoundly Affected by Cholesterol-Fatty Acyl Esterification and the Niemann-Pick C Pathway of Lipid Trafficking J. Biol. Chem., February 27, 2004; 279(9): 8084 - 8092. [Abstract] [Full Text] [PDF]

				Y. Zhang, I. Zanotti, M. P. Reilly, J. M. Glick, G. H. Rothblat, and D. J. Rader Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo Circulation, August 12, 2003; 108(6): 661 - 663. [Abstract] [Full Text] [PDF]

				K. Gillotte-Taylor, M. Nickel, W. J. Johnson, O. L. Francone, P. Holvoet, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I J. Biol. Chem., March 29, 2002; 277(14): 11811 - 11820. [Abstract] [Full Text] [PDF]

				P. M. Yao and I. Tabas Free Cholesterol Loading of Macrophages Is Associated with Widespread Mitochondrial Dysfunction and Activation of the Mitochondrial Apoptosis Pathway J. Biol. Chem., November 2, 2001; 276(45): 42468 - 42476. [Abstract] [Full Text] [PDF]

				D. J. M. Delsing, E. H. Offerman, W. van Duyvenvoorde, H. van der Boom, E. C. M. de Wit, M. J. J. Gijbels, A. van der Laarse, J. W. Jukema, L. M. Havekes, and H. M. G. Princen Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice Circulation, April 3, 2001; 103(13): 1778 - 1786. [Abstract] [Full Text] [PDF]

				C. W. Joyce, G. S. Shelness, M. A. Davis, R. G. Lee, K. Skinner, R. A. Anderson, and L. L. Rudel ACAT1 and ACAT2 Membrane Topology Segregates a Serine Residue Essential for Activity to Opposite Sides of the Endoplasmic Reticulum Membrane Mol. Biol. Cell, November 1, 2000; 11(11): 3675 - 3687. [Abstract] [Full Text]

				T. M. A. Bocan, B. R. Krause, W. S. Rosebury, S. B. Mueller, X. Lu, C. Dagle, T. Major, C. Lathia, and H. Lee The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 70 - 79. [Abstract] [Full Text] [PDF]

				G. Kellner-Weibel, P. G. Yancey, W. G. Jerome, T. Walser, R. P. Mason, M. C. Phillips, and G. H. Rothblat Crystallization of Free Cholesterol in Model Macrophage Foam Cells Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1891 - 1898. [Abstract] [Full Text] [PDF]

				J.-L. Escary, H. A. Choy, K. Reue, X.-P. Wang, L. W. Castellani, C. K. Glass, A. J. Lusis, and M. C. Schotz Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages J. Lipid Res., March 1, 1999; 40(3): 397 - 404. [Abstract] [Full Text]

				P. M. Yao and I. Tabas Free Cholesterol Loading of Macrophages Induces Apoptosis Involving the Fas Pathway J. Biol. Chem., July 28, 2000; 275(31): 23807 - 23813. [Abstract] [Full Text] [PDF]